To address this gap in the literature, we estimated the association between Colorado’s Insulin Affordability Program and (1) out-of-pocket spending, (2) adherence to insulin therapy, and (3) use of health care services for diabetes-related complications. The gene discussed is INS; the disease is diabetes mellitus.